| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Botao Ma, Hongzhen Fan, Siyuan Qi, Fude Yang, Huimei A. Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic. Frontiers in psychiatry. vol 14. 2023-10-02. PMID:37779619. |
effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the covid-19 pandemic. |
2023-10-02 |
2023-10-07 |
Not clear |
| Botao Ma, Hongzhen Fan, Siyuan Qi, Fude Yang, Huimei A. Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic. Frontiers in psychiatry. vol 14. 2023-10-02. PMID:37779619. |
this study aimed to investigate the effect of smoking cessation on plasma clozapine (clo) concentrations in long-term hospitalized chinese male patients with schizophrenia treated with clo during the covid-19 pandemic. |
2023-10-02 |
2023-10-07 |
Not clear |
| Kouji Fukuyama, Eishi Motomura, Motohiro Okad. A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine. Biomolecules. vol 13. issue 9. 2023-09-28. PMID:37759688. |
clozapine is listed as one of the most effective antipsychotics and has been approved for treating treatment-resistant schizophrenia (trs); however, several type a and b adverse reactions, including weight gain, metabolic complications, cardiotoxicity, convulsions, and discontinuation syndromes, exist. |
2023-09-28 |
2023-10-07 |
Not clear |
| Kouji Fukuyama, Eishi Motomura, Motohiro Okad. A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine. Biomolecules. vol 13. issue 9. 2023-09-28. PMID:37759688. |
considering the expressions of gaba-b and iii-mglu receptors (localised in the presynaptic regions), the activation of gaba-b and iii-mglu receptors can explain the distinct therapeutic advantages of clozapine in schizophrenia or trs associated with n-methyl-d-aspartate (nmda) receptor disturbance compared with other atypical antipsychotics via the inhibition of the persistent tonic hyperactivation of thalamocortical glutamatergic transmission in the prefrontal cortex. |
2023-09-28 |
2023-10-07 |
Not clear |
| Anoop Sankaranarayanan, Sharmin Kazi, Chittaranjan Andrad. Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia. Schizophrenia research. 2023-09-28. PMID:37770378. |
we studied the prevalence and predictors of qtc prolongation in treatment-resistant schizophrenia patients who were receiving clozapine in a real-world setting. |
2023-09-28 |
2023-10-07 |
Not clear |
| Nuree Kang, Se Hyun Kim, Jayoun Kim, Sungkyu Kim, Jinhyeok Jang, Heesoo Yoon, Jeonghoon Lee, Minah Kim, Yong Sik Kim, Jun Soo Kwo. Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital. Schizophrenia research. 2023-09-28. PMID:37770376. |
association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a korean tertiary hospital. |
2023-09-28 |
2023-10-07 |
Not clear |
| Thanompong Sathienluckana, Thaksin Jansing, Supakan Srisuriyakamon, Aunchalee Thonkhunthod, Parsiri Sangsuwanto, Pholphat Losatiankij, Suttha Supany. Comparison of the Effectiveness and Safety of Clozapine Between Once-Daily and Divided Dosing Regimen in Patients With Treatment-Resistant Schizophrenia. The Annals of pharmacotherapy. 2023-09-25. PMID:37743679. |
comparison of the effectiveness and safety of clozapine between once-daily and divided dosing regimen in patients with treatment-resistant schizophrenia. |
2023-09-25 |
2023-10-07 |
Not clear |
| Thanompong Sathienluckana, Thaksin Jansing, Supakan Srisuriyakamon, Aunchalee Thonkhunthod, Parsiri Sangsuwanto, Pholphat Losatiankij, Suttha Supany. Comparison of the Effectiveness and Safety of Clozapine Between Once-Daily and Divided Dosing Regimen in Patients With Treatment-Resistant Schizophrenia. The Annals of pharmacotherapy. 2023-09-25. PMID:37743679. |
clozapine is the most effective antipsychotic with respect to the incidence of discontinuation and is indicated for treatment-resistant schizophrenia. |
2023-09-25 |
2023-10-07 |
Not clear |
| Feiyan Yin, Zhidao Shi, Xiquan Ma, Kai Ding, Yuan Zhang, Sha M. Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia. Frontiers in microbiology. vol 14. 2023-09-25. PMID:37744899. |
impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia. |
2023-09-25 |
2023-10-07 |
Not clear |
| Gamze Gürcan, Şevin Hun Şenol, A Elif Anıl Yağcıoğlu, Aygün Ertuğru. Effect of clozapine on suicidality in patients with schizophrenia at a university hospital in Turkey. Schizophrenia research. 2023-09-21. PMID:37735049. |
effect of clozapine on suicidality in patients with schizophrenia at a university hospital in turkey. |
2023-09-21 |
2023-10-07 |
Not clear |
| Edouard-Jules Laforgue, Marion Istvan, Anicet Chaslerie, Pascal Artarit, Geneviève Vallot, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vignea. Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data. Epidemiology and psychiatric sciences. vol 32. 2023-09-19. PMID:37723967. |
characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using french national health insurance data. |
2023-09-19 |
2023-10-07 |
Not clear |
| Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kazuhiko Gomi, Takashi Sakakibara, Shogo Hotta, Satoru Esumi, Kiyotaka Tsubouchi, Yoshihito Shimizu, Shigeki Yamad. Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. BMC psychiatry. vol 23. issue 1. 2023-09-15. PMID:37715155. |
long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. |
2023-09-15 |
2023-10-07 |
Not clear |
| Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kazuhiko Gomi, Takashi Sakakibara, Shogo Hotta, Satoru Esumi, Kiyotaka Tsubouchi, Yoshihito Shimizu, Shigeki Yamad. Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. BMC psychiatry. vol 23. issue 1. 2023-09-15. PMID:37715155. |
clozapine is the only antipsychotic medication with proven efficacy against treatment-resistant schizophrenia. |
2023-09-15 |
2023-10-07 |
Not clear |
| Yachana Panchal, Jessica M Gannon, Janina-Marie Tatar, G K Balasubraman. COVID-19 vaccination among patients with schizophrenia prescribed clozapine. Schizophrenia research. vol 261. 2023-09-10. PMID:37690168. |
covid-19 vaccination among patients with schizophrenia prescribed clozapine. |
2023-09-10 |
2023-10-07 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, Hiroyoshi Takeuch. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023-09-08. PMID:37681448. |
effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: a 1-year retrospective cohort study. |
2023-09-08 |
2023-10-07 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, Hiroyoshi Takeuch. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023-09-08. PMID:37681448. |
thus, we aimed to examine the effect of smoking habits and concomitant vpa use on relapse during the first year after discharge in patients with treatment-resistant schizophrenia (trs) receiving clozapine. |
2023-09-08 |
2023-10-07 |
Not clear |
| Phillipa Louise Brothwood, Mina Husain, Jessica Pinson, Ebenezer Oloyede, Patrick Davey, Eromona Whiske. Clozapine in Combination With Olanzapine Long-Acting Injection: The Intersection of Treatment-Resistant Schizophrenia and Poor Medication Adherence-A Case Report. Journal of clinical psychopharmacology. vol 43. issue 5. 2023-09-08. PMID:37683245. |
clozapine in combination with olanzapine long-acting injection: the intersection of treatment-resistant schizophrenia and poor medication adherence-a case report. |
2023-09-08 |
2023-10-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
clozapine is one of the best atypical antipsychotics and is highly effective in treating treatment-resistant schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
evidence suggests that clozapine appears to be effective in lowering the risk of suicide, extrapyramidal side effects, and relapse in patients with schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
the current study aimed to report the incidence of eosinophilia associated with clozapine use in patients with schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |